Valuein

Overview

MCKESSON CORP

MCKNYSEHealth CareWholesale-Drugs, Proprietaries & Druggists' SundriesCIK 0000927653Large-cap benchmark

Latest 10-K: FY2026, filed May 8, 2026 · Open the 10-K (Inline XBRL) ↗

Revenue
$403.43B
12.4%YoYup from FY2025
TotalRevenue
Gross profit
$14.55B
9.2%YoYup from FY2025
GrossProfit
Operating income
$6.21B
40.5%YoYup from FY2025
OperatingIncome
Net income
$4.76B
44.5%YoYup from FY2025
NetIncome
Diluted EPS
$38.38
49.2%YoYup from FY2025
EPSDiluted
Diluted shares
124.1M
3.1%YoYdown from FY2025
WeightedAvgSharesDiluted

At a glance

Growth

  • MCKESSON CORP reported revenue of $403.43B for fiscal 2026, up 12.4% from fiscal 2025.
  • Revenue grew faster than the median S&P 500 member in 4 of the last 4 fiscal years.

Profitability

  • Operating margin was 1.5% and net margin was 1.2%.

Per share

  • Diluted EPS was $38.38, up 49.2% from the prior year.
Loading insider and institutional summary

Written from the filed figures on this page by fixed rules — no AI.

Data as of Oct 31, 2026 · Sources: SEC EDGAR 10-K

Financial statements

Annual figures from the 10-K, most recent fiscal year first.

Income Statement

5 annual periods

Chip: YoY change.

Income Statement, annual, newest fiscal year first. 4Y CAGR: compound annual growth from the oldest to the newest year shown. Muted line: large-cap benchmark median change. Line under a label: how many large-cap benchmark companies its median rests on.
Line itemFY2026FY2025FY2024FY2023FY20224Y CAGR
Revenue
$403.43B12.4%up
$359.05B16.2%up
Benchmark median 6.4%
$308.95B11.7%up
Benchmark median 4.5%
$276.71B4.8%up
Benchmark median 4.8%
$263.97B10.8%up
Benchmark median 10.3%
11.2%
Gross Profit
Median of 315 / 498
$14.55B9.2%up
$13.32B3.9%up
Benchmark median 6.8%
$12.83B3.8%up
Benchmark median 5.5%
$12.36B5.9%down
Benchmark median 5.2%
$13.13B8.1%up
Benchmark median 8.3%
2.6%
Operating Income
Median of 373 / 498
$6.21B40.5%up
$4.42B13.1%up
Benchmark median 7.3%
$3.91B10.8%down
Benchmark median 7.4%
$4.38B115.0%up
Benchmark median 4.9%
$2.04Bn/m
Benchmark median 7.5%
32.1%
Net Income
$4.76B44.5%up
$3.29B9.8%up
Benchmark median 4.8%
$3.00B15.7%down
Benchmark median 5.7%
$3.56B219.6%up
Benchmark median 1.9%
$1.11Bn/m
Benchmark median 1.3%
43.8%
EPS (Diluted)
$38.3849.2%up
$25.7214.9%up
Benchmark median 6.2%
$22.3910.5%down
Benchmark median 7.9%
$25.03246.2%up
Benchmark median 1.9%
$7.23n/m
Benchmark median 1.5%
51.8%

Balance Sheet

5 annual periods

Chip: YoY change.

Balance Sheet, annual, newest fiscal year first. 4Y CAGR: compound annual growth from the oldest to the newest year shown. Muted line: large-cap benchmark median change. Line under a label: how many large-cap benchmark companies its median rests on.
Line itemFY2026FY2025FY2024FY2023FY20224Y CAGR
Total Assets
$82.32B9.6%up
$75.14B11.4%up
Benchmark median 5.6%
$67.44B8.2%up
Benchmark median 3.4%
$62.32B1.5%down
Benchmark median 4.1%
$63.30B2.6%down
Benchmark median 2.2%
6.8%
Total Liabilities
Median of 357 / 498
—
—
—
—
—
—
Stockholders' Equity
negative: -$1.78Bn/m
negative: -$1.69Bn/m
Benchmark median 6.8%
negative: -$1.60Bn/m
Benchmark median 5.4%
negative: -$1.49Bn/m
Benchmark median 7.3%
negative: -$1.79B1124.0%down
Benchmark median 2.5%
n/m
Cash & Equivalents
$3.98B30.2%down
$5.69B24.2%up
Benchmark median 5.2%
$4.58B2.0%down
Benchmark median 1.9%
$4.68B32.4%up
Benchmark median 6.7%
$3.53B43.7%down
Benchmark median -8.6%
3.0%
Total Debt
$6.50B14.0%up
$5.70B1.8%up
Benchmark median 2.1%
$5.60B0.0%unchanged
Benchmark median 0.2%
$5.60B5.1%down
Benchmark median 0.3%
$5.90B16.9%down
Benchmark median 0.1%
2.5%

Cash Flow Statement

5 annual periods

Chip: YoY change.

Cash Flow Statement, annual, newest fiscal year first. 4Y CAGR: compound annual growth from the oldest to the newest year shown. Muted line: large-cap benchmark median change. Line under a label: how many large-cap benchmark companies its median rests on.
Line itemFY2026FY2025FY2024FY2023FY20224Y CAGR
Operating Cash Flow
$6.16B1.2%up
$6.08B41.1%up
Benchmark median 6.3%
$4.31B16.4%down
Benchmark median 4.8%
$5.16B16.4%up
Benchmark median 9.9%
$4.43B2.4%down
Benchmark median -0.7%
8.5%
Capital Expenditures
$436.00M18.8%down
$537.00M24.6%up
Benchmark median 5.4%
$431.00M10.5%up
Benchmark median 2.8%
$390.00M0.5%up
Benchmark median 11.3%
$388.00M14.0%down
Benchmark median 14.0%
3.0%
Free Cash Flow
Median of 378 / 498
$5.72B3.1%up
$5.55B42.9%up
Benchmark median 7.3%
$3.88B18.6%down
Benchmark median 6.1%
$4.77B17.9%up
Benchmark median 8.8%
$4.05B1.1%down
Benchmark median -11.3%
9.0%

n/m: not meaningful — the base (the prior year, or the first year for the CAGR) was zero or negative, or a per-share figure’s share basis changed (stock split). “—” means the figure is not available.

Benchmark median = median of the companies in the benchmark universe on Dec 31 of each fiscal year, from their own 10-K filings; a change counts only companies whose prior year was positive. Each median uses every member that reports the line item; where fewer than 80% do (banks and insurers file no gross profit), the row names how many. Published where at least 250 companies report it. Updated 2026-10-27. This compares reported figures, not share-price returns. Methodology

Ratios & valuation

FY2026

Every ratio read two ways: Wall Street’s popular formula and the value investor’s stricter one. Same question, same unit. Pick a ratio.

Valuation · Earnings yield

What a dollar of market value earned

4.4%

Wall Street

on net earnings

FY2025 3.8%

5.3%

Value investor

on free cash flow

FY2025 6.4%

Gap +0.9 pts: Value-investor figure 0.9 points higher

How it’s calculated

Wall Street · on net earnings

Diluted EPS ÷ fiscal-year-end share price (1 ÷ P/E)

pe_ratio (ratio table)

P/E 22.5×

Value investor · on free cash flow

(Operating cash flow − capital expenditures) ÷ market capitalisation (fiscal-year-end close × weighted-average diluted shares)

free cash flow ÷ market cap

Each ratio measures one thing two ways, in the same unit: the popular formula, then a stricter one, so a lower figure is the stricter reading. Gap = value-investor figure minus Wall Street figure, from the figures shown.

Price-based ratios use the fiscal-year-end closing price. Free cash flow = operating cash flow − capital expenditures (we compute it; filings rarely report it). n/m = not meaningful (denominator ≤ 0); “—” = not reported. Each ratio’s formulas are under “How it’s calculated”.

Loading capital allocation

Smart money

Loading insider and institutional activity

Showing the most recent 5 annual periods. Get longer history on the Pro plan, or the full history (1993–present) plus the smart-money dataset and webhooks on Institutional.

Peers, filings & research

Loading sector peers
Loading recent filings

Research Reports

No published research on MCK yet.

Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows on data pinned to its SEC filing. Be the first: run equity_research_brief on MCK and publish the result to your public profile.

Loading the data behind this page

Cite this page

Data as of Oct 31, 2026. Canonical address: https://valuein.biz/data/MCK

APA-style text
Valuein. (2026, October 31). MCKESSON CORP (MCK) financial statements, earnings power and smart-money summary [Data set]. Source: SEC EDGAR filings. https://valuein.biz/data/MCK
BibTeX
@misc{valuein_mck_2026,
  author = {{Valuein}},
  title = {MCKESSON CORP (MCK) financial statements, earnings power and smart-money summary},
  year = {2026},
  howpublished = {\url{https://valuein.biz/data/MCK}},
  note = {Data as of 2026-10-31; source: SEC EDGAR filings}
}
Open 10-K in SEC Inline XBRL viewer

10-K filed May 8, 2026 · accession 0000927653-26-000069

Agents: every figure Valuein's tools return carries a fact_id that traces to its SEC filing.

point-in-time · survivorship-free · every number traceable to its SEC filing

Index names are trademarks of their owners; Valuein is not affiliated with or endorsed by any index provider.